Pressure Biosciences, Target Discovery Partner on Tissue Prep | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Pressure Biosciences and Target Discovery have struck a multi-faceted agreement covering the development, manufacture, and co-marketing of reagents, PBI said today.

Under the agreement, TDI has licensed PBI to make and sell a line of TDI reagents that were designed to be used with PBI's Pressure Cycling Technology for preparing tissues for scientific analysis.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.